ClinicalTrials.gov
public full text
Public Domain
Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo
A randomised, double-blind, placebo-controlled, 4-period incomplete block crossover study of single oral dose GSK835726 (100mg, 50mg, 10mg), Cetirizine (10mg) and placebo to evaluate the efficacy and safety using an Environmental challenge chamber in male subjects with seasonal allergic rhinitis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis#826260
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis#877316
- 723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover#896785
- Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis#1044375
- An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo#892537
Record · ID 1125525
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive